首页> 外文期刊>Bone marrow transplantation >LETTER TO THE EDITOR Hepatosplenic alpha beta T-cell lymphoma successfully treated with allogeneic bone marrow transplantation
【24h】

LETTER TO THE EDITOR Hepatosplenic alpha beta T-cell lymphoma successfully treated with allogeneic bone marrow transplantation

机译:致编辑的信异基因骨髓移植成功治疗了肝脾αβT细胞淋巴瘤

获取原文
获取原文并翻译 | 示例
       

摘要

Hepatosplenic T-cell lyraphoma (HSTCL) is a rare type of peripheral T-cell lymphoma characterized in young adult males by hepatosplenomegaly, B-symptoms, peripheral blood cytopenias and no lymphadenopathy; lymphomatous infiltrates in the splenic red pulp, hepatic sinusoids and bone marrow sinuses; T cell receptor (TCR) gamma delta-chain and cytotoxic T-cell phenotype; isochromosome (i) 7q in conjunction with other abnormalities, most commonly trisomy 8; and aggressive clinical course.
机译:肝脾T细胞淋巴瘤(HSTCL)是一种罕见的外周T细胞淋巴瘤,其特征是年轻成年男性具有肝脾肿大,B症状,外周血细胞减少和无淋巴结肿大;脾红浆,肝窦和骨髓窦中有淋巴瘤浸润; T细胞受体(TCR)γδ链和细胞毒性T细胞表型;异染色体(i)7q合并其他异常,最常见的是三体性8;和积极的临床过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号